An international pharmaceutical group

RECORDATI, established in 1926, is an international pharmaceutical group, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations worldwide, including in the BeNeLUX.

Recordati is committed to the research and development of new specialties with a focus on treatments for Rare Diseases and Specialty and Primary Care.


Specialty and Primary Care

RECORDATI, active in the BENELUX since 2018, offers medicines for different therapeutic domains such as Cardiology, Gastroenterology and Psychiatry. Recordati is committed to discover and develop innovative products with added value that improve quality of life and help people to live longer, healthier and more productively.

Rare diseases

The RECORDATI group operates in the rare diseases segment worldwide through its dedicated subsidiary Recordati Rare Diseases. Recordati Rare Diseases has a robust portfolio of therapies that target a wide range of medical conditions, and are designed to meet the needs of underserved patient populations. Recordati Rare Diseases is committed to supporting families affected by rare diseases through the research and development of new therapies and the distribution of specific scientific knowledge throughout the medical community. We believe that every patient has the right to the best possible treatment, especially patients with rare diseases.

2021/001/RecBE – January – Date of approval 02/2021